Preoperative GLP-1 Drug Use Reduces Revisions After Spinal Fusion Surgery | Research

The takeaway

Perioperative GLP-1 RA use was associated with reduced revision surgery and complications after spinal fusion, supporting their anti-inflammatory and osteogenic effects on surgical outcomes.

Fewer revisions
Spine surgery patients on GLP-1 drugs had fewer revision surgeries — the drugs' anti-inflammatory and bone-building effects may improve fusion outcomes

What the researchers found

Perioperative GLP-1 RA use: reduced revision surgery and complications after spinal fusion, supporting anti-inflammatory and osteogenic benefits for surgical healing.

Why it matters

Spine surgery revisions are costly and debilitating. A medication that reduces revision rates could improve thousands of patients' outcomes.

How the study worked

Retrospective cohort study of spinal fusion patients comparing perioperative GLP-1 RA users to non-users for revision rates and complications.

What this study cannot tell us

Retrospective. Cannot prove causation. Selection bias possible.

How to read the evidence

Retrospective cohort. Consistent with other surgical GLP-1 benefit data.

When this study was published

Published in 2025.

The bigger picture

GLP-1 drugs may improve surgical outcomes beyond spine — their anti-inflammatory and tissue-healing properties could benefit all surgeries.

Questions still open

Should GLP-1 drugs be started preoperatively for planned spine surgery?
Do the osteogenic effects enhance bone graft integration?
Would prospective spine surgery trials of GLP-1 drugs be warranted?

Common questions

Should I take my GLP-1 drug before spine surgery?

This study suggests GLP-1 drugs may actually improve spine surgery outcomes by reducing revisions and complications through anti-inflammatory and bone-healing effects.

Could GLP-1 drugs help bones heal?

Yes — GLP-1 drugs have osteogenic (bone-building) properties. In this study, spine fusion patients on GLP-1 drugs had better outcomes, possibly due to enhanced bone healing.

Read the original research

Perioperative GLP-1 Receptor Agonist Use is Associated With Reduced Revisions and Complications Following ACDF: A Propensity-Matched Analysis.

Global spine journal, 21925682261419753

View on PubMed ↗Publisher’s paper ↗

Citation

Kim, Matthew T; Lee, Seungjun; Goh, Graham S; Riew, K Daniel. (2026). Perioperative GLP-1 Receptor Agonist Use is Associated With Reduced Revisions and Complications Following ACDF: A Propensity-Matched Analysis.. Global spine journal, 21925682261419753. https://doi.org/10.1177/21925682261419753